Overview Request Sample Pages Request Customization Download PDF
You are viewing: Netherlands Cardiac Monitoring & Rhythm Management Devices Market analysis

The Netherlands Cardiac Monitoring & Rhythm Management Devices Market was valued at $62.9 Million in 2026 and projected to reach to $74.3 Million by 2031, representing a compound annual growth rate of 3.4%. The Netherlands cardiac monitoring and rhythm management devices market is positioned for steady growth through 2031, driven by an aging population and increasing prevalence of cardiac arrhythmias.

Netherlands Cardiac Monitoring & Rhythm Management Devices Market Trends and Insights

  • In the Netherlands, aging demographics and rising prevalence of atrial fibrillation and heart failure are driving adoption of advanced monitoring technologies.
  • The Netherlands benefits from a well-developed healthcare infrastructure and strong reimbursement policies that support the deployment of innovative cardiac devices across hospitals and outpatient settings. The Netherlands market reflects steady growth driven by increasing patient awareness and physician adoption of remote monitoring solutions.
  • By 2031, the Netherlands is expected to see expanded integration of wearable cardiac devices and implantable loop recorders in clinical practice.
  • Healthcare providers in the Netherlands are investing in digital health platforms to enhance patient outcomes, positioning the country as a key market for rhythm management innovation in Europe..

Key Market Statistics

  • CAGR (2026-2031) 3.4% CAGR
  • Market Size, 2026 ~USD 62.9 Million
  • Forecast, 2031 ~USD 74.3 Million
  • Country Netherlands

Netherlands Cardiac Monitoring & Rhythm Management Devices Market Overview

Market Size & Growth :

The Netherlands cardiac monitoring and rhythm management devices market is valued at USD 62.9 million in 2026 and is projected to reach USD 74.3 million by 2031, with a CAGR of 3.4%.

Aging Population Driver :

Netherlands' aging demographics are significantly driving adoption of advanced cardiac monitoring technologies, as elderly populations face higher incidence of arrhythmias and heart conditions requiring continuous monitoring.

Atrial Fibrillation Prevalence :

Rising prevalence of atrial fibrillation in the Netherlands is accelerating demand for rhythm management devices, including implantable cardioverter-defibrillators and pacemakers for disease management.

Healthcare Infrastructure :

The Netherlands benefits from advanced healthcare infrastructure and high adoption rates of innovative medical technologies, supporting market penetration of next-generation cardiac monitoring solutions.

Netherlands Cardiac Monitoring & Rhythm Management Devices Market Dynamics

  • Healthcare providers in the Netherlands are increasingly adopting remote monitoring technologies and wearable devices to improve patient outcomes and reduce hospital readmissions.
  • The market's 3.4% CAGR reflects moderate but consistent expansion as reimbursement policies support advanced monitoring solutions and clinical evidence validates their efficacy in managing heart failure and atrial fibrillation.
  • Investment in digital health infrastructure and integration with electronic health records will further enhance market adoption among Dutch healthcare institutions..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The Netherlands market is valued at USD 62.9 million in 2026 and will grow to USD 74.3 million by 2031 at a 3.4% CAGR.
    • Aging population and rising atrial fibrillation prevalence are key growth drivers in the Netherlands.
    • The Netherlands has strong healthcare infrastructure and reimbursement support for cardiac devices.
    • Remote monitoring and wearable technologies are expanding adoption in the Netherlands by 2031.

    Cardiac Monitoring & Rhythm Management Devices Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment HOME CARE SETTINGS (End User)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.3% from 2026 to 2031
    Largest Segment ARRHYTHMIAS (Application)
    Market Size Base Year (Billions) ~USD 27.91 (2026)
    Revenue Forecast (Billions) ~USD 37.88 (2031)
    Segments Covered Type, Application, End User, Type 2024–2031

    Netherlands Cardiac Monitoring & Rhythm Management Devices Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Type

    • Ambulatory Cardiac Monitors
    • Automated External Defibrillators (Aed)
    • Automated External Defibrillators (Aeds)
    • Cardiac Resynchronization Therapy (Crt)
    • Cardiac Resynchronization Therapy Defibrillators
    • Cardiac Resynchronization Therapy Pacemakers (Crt-P)
    • Cardiac Resynchronization Therapy Pacemakers(Crt-P)
    • Cardiac Resynchronization Therapy- Defibrillators (Crt-Ds)
    • Crt- Pacemaker
    • Defibrillators
    • Dual-Chamber Icds
    • Dual-Chamber Implantable Cardioverter-Defibrillators (Icds)
    • Dual-Chamber Pacemakers
    • Electrocardiogram (Ecg / Ekg) Monitors
    • Electrocardiogram (Ecg/Ekg) Monitors
    • Event Monitors
    • External Defibrillation Devices
    • External Defibrillators
    • Handheld/ Smart Ecg Monitors
    • Handheld/Smart Ecg Monitors
    • Holter Monitors
    • Holter Monitors (Short Term)
    • Implantable Cardioverter-Defibrillators (Icds)
    • Invasive Cardiac Monitoring Devices
    • Leadless Chamber Pacemakers
    • Long-Term Continuous Ecg Monitors
    • Manual External Defibrillator / Monitor Units
    • Manual External Defibrillator /Monitor Units
    • Manual External Defibrillators
    • Mobile Cardiac Telemetry (Mct) Devices
    • Mobile Cardiac Telemetry Devices (Mct)
    • Non-Invasive Cardiac Monitoring Devices
    • Pacemakers
    • Patch-Based Ecg Monitors (Long Term, Extended Wear)
    • Single- Chamber Icds
    • Single- Chamber Pacemakers
    • Single-Chamber Implantable Cardioverter-Defibrillators (Icds)
    • Single-Chamber Pacemakers
    • Standard 12-Lead Ecg Machines (Resting Ecg Monitors)
    • Stress Ecg System
    • Stress Ecg Systems
    • Subcutaneous Icds
    • Subcutaneous Implantable Cardioverter-Defibrillators (Icds)
    • Wearable Cardioverter Defibrillators (Wcds)
    • Wearable Cardioverter-Defibrillators (Wcds)

    By Application

    • Arrhythmias
    • Heart Failure
    • Heart Failure (Hf)
    • Myocardial Infarction (Mi)
    • Myocardial Infraction (Mi)
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Cardiac Centers
    • Cardiac Centres
    • Home Care Settings
    • Hospitals
    • Other End Users
    • Primary Care Centers
    • Primary Care Centres

    By Type 2024–2031

    • Event Monitors
    • Holter Monitors
    • Long-Term Continuous Ecg Monitors
    • Mobile Cardiac Telemetry (Mct) Devices

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Netherlands-specific market data to develop localized product strategies, identify growth opportunities in cardiac monitoring segments, and optimize pricing and distribution for the Dutch healthcare system.
    • Healthcare Providers & Hospitals : Dutch hospitals and cardiac centers require market intelligence to benchmark device adoption rates, evaluate technology investments, and understand competitive offerings in rhythm management and monitoring solutions.
    • Investors & Private Equity : Investment firms targeting the Dutch healthcare sector need accurate market sizing and growth projections to evaluate acquisition targets, assess portfolio company performance, and identify emerging opportunities in cardiac devices.
    • Healthcare Consultants : Consulting firms advising Dutch healthcare organizations and device manufacturers require country-specific market data to support strategic planning, market entry analysis, and competitive positioning recommendations.
    • Regulatory & Reimbursement Bodies : Dutch healthcare policymakers and reimbursement authorities need market data to inform coverage decisions, assess health economic value, and develop guidelines for cardiac monitoring device adoption and pricing.

    Key Companies in the Netherlands Cardiac Monitoring & Rhythm Management Devices Market

    CompanyHQOwnershipStrongest segments
    KINDRED HEALTHCARE INC.United StatesPrivate CompanyLong-term acute care hospital services,Inpatient rehabilitation facilities,Contract rehabilitation and ancillary services,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, Hall power tools, arthroscopy ecosystem),General Surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgical systems),Endoscopic Technologies (GI therapeutic/diagnostic) & Patient Monitoring,
    HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution & Value-Added Services,Global Specialty Products,Global Technology,
    ST JUDE MEDICAL, INCUnited StatesPrivate CompanyCardiac Rhythm Management (pacemakers, ICDs, CRT devices),Heart Failure & Hemodynamic Monitoring (CRT-HF, VADs, CardioMEMS HF system),Atrial Fibrillation & Electrophysiology (catheters, mapping, ablation, LAA closure),
    ZOLL MEDICAL CORPORATIONUnited StatesPrivate CompanyDefibrillators and monitors (hospital and EMS),Automated external defibrillators (public access and professional),LifeVest and wearable defibrillation solutions,
    SANOFIFrancePublic CompanyPediatric and Combination Vaccines (polio, pertussis, Hib, hexavalent),Other Vaccines (RSV, hepatitis A, typhoid, yellow fever, rabies),Immunology and Inflammation Therapies,
    AT&SCanadaPublic CompanyTurnkey automated manufacturing and assembly systems,Pre- and post-automation lifecycle services,Software and digital solutions,
    X-FABBelgiumPublic CompanyAnalog/mixed-signal CMOS ICs,MEMS (sensors and actuators),Silicon carbide and gallium nitride,
    MERIT MEDICALUnited StatesPublic CompanyCardiovascular (cardiac intervention, peripheral intervention, hemodynamic monitoring, fluid management, hemostasis),Oncology and Spine (soft tissue biopsy, embolotherapy, vertebral augmentation, RFA, bone biopsy),Endoscopy (gastroenterology and pulmonary products, stents, balloon dilators, cryoballoon devices),
    GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (Ultrasound and Interventional),Patient Care Solutions,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy Systems and Devices,Monitoring and Enterprise Informatics,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral, electrophysiology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.ChinaPublic CompanyPatient monitoring & life-support (including ventilators, defibrillation, AED, anesthesia),Ultrasound & medical imaging (including radiology, emergency ultrasound, endoscope camera systems),In-vitro diagnostics (CLIA, chemistry, hematology),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    STRYKERUnited StatesPublic CompanyOrthopaedics (hips, knees, shoulder, ankle, trauma and extremities, Mako Shoulder),MedSurg (surgical equipment, patient handling, emergency medical equipment, intensive care disposables),Neurotechnology and Spine (stroke, hemorrhagic, venous thromboembolism, brain surgery, orthobiologics, biosurgery),
    NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors & clinical information systems,Physiological measuring equipment (EEG/ECG/EMG and related),Defibrillators, AEDs, ventilators, anesthesia and therapeutic devices,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,
    FUKUDA DENSHIJapanPublic CompanyResting ECG and Stress Test Systems,Patient Monitoring Systems (bedside, central, transmitters),Vascular Screening and Data Management Software,
    OSI SYSTEMS, INC.United StatesPublic CompanySecurity (Rapiscan, S2 turnkey solutions),Healthcare (Spacelabs patient and connected monitoring),Optoelectronics and Manufacturing (devices, EMS, LCDs),
    IRHYTHM INC.United StatesPublic CompanyZio XT System (long-term continuous ECG monitoring services),Zio Monitor System and Zio ECG Utilization Software,Zio AT System (mobile cardiac telemetry and near-real-time monitoring),
    LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.ChinaPublic CompanyCardiac interventional and cardiovascular devices,In vitro diagnostics and ultrasound imaging,Peripheral vascular, blood purification, and surgical instruments,

    KINDRED HEALTHCARE INC.

    Kindred Healthcare Inc. is a private healthcare company founded in 1985 in the United States, operating with a workforce of 64,200 employees.

    CONMED CORPORATION

    CONMED Corporation is a public medical device company established in 1970 in the United States, employing 3,900 people.

    HENRY SCHEIN

    Henry Schein is a public company founded in 1932 in the United States with 25,000 employees, operating in the healthcare distribution sector.

    ST JUDE MEDICAL, INC

    St Jude Medical, Inc. is a private medical device company established in 1976 in the United States with 18,000 employees.

    ZOLL MEDICAL CORPORATION

    ZOLL Medical Corporation is a private medical device manufacturer founded in 1980 in the United States with 1,908 employees.

    SANOFI

    Sanofi is a public pharmaceutical company founded in 1994 in France with 74,846 employees.

    AT&S

    AT&S is a public company founded in 1978 in Canada with 7,000 employees.

    X-FAB

    X-FAB is a public semiconductor company founded in 1992 in Belgium with 4,300 employees.

    MERIT MEDICAL

    Merit Medical is a public medical device company founded in 1987 in the United States with 7,500 employees.

    GE HEALTHCARE

    GE Healthcare is a public healthcare company founded in 2022 in the United States with 54,000 employees.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a public multinational company founded in 1891 in the Netherlands with 64,317 employees.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.

    MEDTRONIC

    Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees.

    SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

    Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a public medical device manufacturer founded in 1991 in China with 21,288 employees.

    ABBOTT

    Abbott is a public healthcare company founded in 1888 in the United States with 115,000 employees.

    STRYKER

    Stryker is a public medical device and pharmaceutical company founded in 1941 in the United States with 56,000 employees.

    NIHON KOHDEN CORPORATION

    Nihon Kohden Corporation is a public medical device company founded in 1951 in Japan with 6,116 employees.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a public medical device company founded in 1998 in China with 6,547 employees.

    FUKUDA DENSHI

    Fukuda Denshi is a public medical device manufacturer founded in 1939 in Japan with 3,497 employees.

    OSI SYSTEMS, INC.

    OSI Systems, Inc. is a public technology company founded in 1987 in the United States with 7,337 employees.

    IRHYTHM INC.

    iRhythm Inc. is a public digital health company founded in 2006 in the United States with 2,400 employees.

    LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

    Lepu Medical Technology (Beijing) Co., Ltd. is a public medical device company founded in 1999 in China with 8,689 employees.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise market valuations for the Netherlands (USD 62.9M in 2026, USD 74.3M in 2031) with country-specific CAGR of 3.4%, enabling accurate budget allocation and revenue projections for Dutch market operations.
    • Demographic & Clinical Insights : Understand Netherlands-specific drivers including aging population trends, atrial fibrillation prevalence, and heart failure incidence that directly influence device adoption rates and market opportunities in this mature healthcare market.
    • Competitive Landscape Analysis : Identify key players and competitive dynamics specific to the Dutch market, including local healthcare provider preferences, reimbursement structures, and regulatory requirements affecting market entry and growth strategies.
    • Healthcare System Integration : Gain insights into Netherlands' advanced healthcare infrastructure, digital health adoption, and integration capabilities that shape technology adoption patterns and create opportunities for remote monitoring and connected device solutions.
    • Strategic Market Positioning : Develop targeted go-to-market strategies for the Netherlands by understanding local clinical guidelines, hospital procurement processes, and patient demographics to maximize market penetration and competitive advantage.

    Frequently asked questions

    What is the market size of cardiac monitoring devices in the Netherlands in 2026?

    The Netherlands cardiac monitoring and rhythm management devices market is valued at USD 62.9 million in 2026.

    What is the projected market size for the Netherlands by 2031?

    The Netherlands market is projected to reach USD 74.3 million by 2031.

    What is the CAGR for the Netherlands cardiac monitoring market?

    The Netherlands cardiac monitoring and rhythm management devices market is growing at a compound annual growth rate of 3.4% from 2026 to 2031.

    What factors are driving growth in the Netherlands cardiac devices market?

    Key drivers in the Netherlands include aging demographics, rising prevalence of atrial fibrillation and heart failure, strong healthcare infrastructure, and favorable reimbursement policies.

    Which technologies are gaining adoption in the Netherlands market?

    Remote monitoring solutions, wearable cardiac devices, and implantable loop recorders are increasingly adopted in the Netherlands healthcare system.

    RESEARCH METHODOLOGY

    The study involved four major activities in estimating the current size of the cardiac monitoring and cardiac rhythm management devices market. Exhaustive secondary research was conducted to gather information on the market and its subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (cardiologists, Surgeons, Cardiac consultants) and supply sides (cardiac monitoring & cardiac rhythm management devices providers and distributors).

    The following is a breakdown of the primary respondents:

    Cardiac Monitoring & Rhythm Management Devices Market

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2. Tiers of companies are defined based on their total revenue. As of 2025: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac monitoring & cardiac rhythm management devices Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry and markets have been identified through extensive secondary research
    • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
    Cardiac Monitoring & Rhythm Management Devices Market

    Data Triangulation

    After arriving at the overall market size through market sizing processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the cardiac monitoring & cardiac rhythm management devices industry.

    Market Definition

    Cardiac monitoring is the continuous monitoring of cardiac activity using devices such as electrocardiographs, recording devices, and visual/audible recorders. These devices are used to identify or rule out a cardiac rhythm disorder and determine the appropriate course of treatment. Cardiac rhythm management devices include implantable devices (defibrillators and pacemakers), leads, and external devices used to treat and manage arrhythmia-related diseases. The major end users of implantable pacemakers and defibrillators are hospitals, cardiac centers, clinics, and ambulatory surgery centers.

    Stakeholders

    • Manufacturers of cardiac monitoring devices and rhythm management devices
    • Distributors of cardiac monitoring devices and rhythm management devices
    • Hospitals, primary care centers, and cardiac centers
    • Ambulatory surgical centers
    • Non-government organizations
    • Government regulatory authorities
    • Contract manufacturers & third-party suppliers
    • Research laboratories & academic institutes
    • Clinical research organizations (CROs)
    • Government & non-governmental regulatory authorities
    • Market research & consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global cardiac monitoring and cardiac rhythm management devices market, by type, application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze the regulatory scenario, value chain analysis, supply chain analysis, Porter’s Five Forces analysis, ecosystem analysis, trade analysis, pricing analysis, patent analysis, impact of AI, case study analysis, unmet needs/end-user expectations, impact of US tariffs, and trends/disruption impacting customers’ business in the market.
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze the opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
    • To strategically analyze the cardiac monitoring and cardiac rhythm management devices market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To track and analyze competitive developments, including acquisitions, product & service launches, partnerships, and expansions, in the cardiac monitoring and cardiac rhythm management (CM & CRM) devices market.
    • To track and analyze competitive developments such as acquisitions, product launches & enhancements, partnerships, agreements, contracts, & collaborations, and R&D activities in the CM & CRM devices market.

    Get the Full Cardiac Monitoring & Rhythm Management Devices Market Report

    Full forecast, segment splits, and company analysis for all Cardiac Monitoring & Rhythm Management Devices Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status